A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical ...

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

Zetagen Therapeutics, Inc., a private, clinical stage, biopharmaceutical company focused on developing breakthrough therapies, via local administration, for metastatic and primary breast cancers, ...

Scientists from Institut Curie, the CNRS, and Inserm have just created a novel class of molecules capable of destroying ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer ...

A Minnesota woman was told her stage 4 colon cancer couldn’t be cured. Two years later, she’s cancer-free — and says a ...

Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the first quarter ended March 31, 2025, ...

28, 2025 — A highly sensitive bone marrow test ... of several forms of blood cancer using a drug already in clinical trials against breast ... New Innovative Local Treatment for Osteolytic ...